Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|December 28, 2014
A novel approach to patient self-monitoring of sonographic examinations using a head-mounted displayMasaharu Inoue, Kazunori Kihara, Soichiro Yoshida, et al.
World Journal of Surgical Oncology|June 8, 2022
Paraganglioma of the urinary bladder initially diagnosed as gastrointestinal stromal tumor requiring combined resection of the rectum: a case reportNatsumi Matsuzawa, Takeshi Nishikawa, Riki Ohno, et al.
Internal Medicine (Tokyo, Japan)|July 5, 2026
Late-diagnosed Nonclassical 21-hydroxylase Deficiency in Two Elderly Men with Adrenal Incidentalomas: Clinical Clues to the Underlying DiagnosisMasahiro Nezu, Yuto Yamazaki, Kazumasa Tanaka, et al.
Endocrine Journal|January 20, 2022
A case of juvenile-onset pheochromocytoma with KIF1B p.V1529M germline mutationMasahiro Nezu, Yosuke Hirotsu, Kenji Amemiya, et al.
Anticancer Research|January 30, 2022
Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial CarcinomaRyo Kurashina, Kiyohiro Ando, Masaharu Inoue, et al.
Cancer Diagnosis & Prognosis|March 6, 2023
Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial CarcinomaRyo Kurashina, Kiyohiro Ando, Masaharu Inoue, et al.
Urologia Internationalis|October 22, 2018
Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial NephrectomyNaoko Kawamura, Kazutaka Saito, Masaharu Inoue, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 13, 2026
Mixed Response to Nivolumab Among Different Metastatic Sites in Patients With Metastatic Renal Cell Carcinoma: Incidence and Clinical ImplicationsYudai Ishikawa, Hajime Tanaka, Yoshitomo Yamaguchi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 15, 2010
[Result of treatment for advanced germ cell tumor in the last decade]Jun-Ichiro Ishioka, Yukio Kageyama, Masaharu Inoue, et al.
Pageof 6